| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $723K | — | +0.0% |
| SG&A Expense | $5.0M | -8.9% | -32.2% |
| Operating Income | $1.3M | +165.8% | +114.3% |
| Pre-tax Income | -$3.6M | +49.8% | +57.5% |
| Income Tax | $2K | — | — |
| Net Income | -$4.7M | +43.5% | +39.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.1M | -11.7% | -9.5% |
| Total Assets | $61.5M | -3.2% | +79.8% |
| Total Liabilities | $1.9M | +8.4% | -68.8% |
| Stockholders' Equity | $59.7M | -3.5% | +106.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | — |
| Capital Expenditures | $26K | — | — |
| Investing Cash Flow | -$26K | — | — |
| Financing Cash Flow | -$518K | — | — |
| Free Cash Flow | -$5.3M | — | — |